Is Your Medical Billing Company Underperforming and Draining Your Revenue?

Yes  — if your Net Collection Ratio sits below 92%, your AR over 90 days has crossed the 20% threshold, or your denial rate is climbing past 5%, your medical billing company is underperforming and actively costing your group $150,000 to $400,000 in recoverable revenue every year.

The damage rarely announces itself. Denial rates inch up by fractions of a percent each quarter. Days in AR stretch by two or three days at a time. Monthly reports still arrive on schedule, and claims still get submitted. The dysfunction lives entirely in the delta  the gap between what your vendor collects and what a specialty-optimized revenue cycle operation is built to protect.

According to the CMS National Health Expenditure Data, U.S. healthcare spending reached $5.3 trillion in 2024, growing 7.2% year-over-year. At that scale, even a 2% efficiency gap in your revenue cycle translates to tens of thousands of dollars written off every month  silently, and without a single alert from your billing dashboard.

The Triple Threat Quietly Eroding Your Margin

A medical billing company underperforming at an enterprise level fails across three predictable dimensions. Understanding each one is the first step to quantifying what recovery actually looks like.

1. Payer Contract Leakage

Most billing vendors submit claims without validating reimbursement against contracted rates at the CPT code level. For a group managing 8-12 active payer contracts and hundreds of procedure codes, underpayments of 3-6% go undetected for months. On a $5M annual billing volume, that’s $150,000-$300,000 in legitimate reimbursement quietly absorbed as “contractual adjustment.”

2. Denial Pattern Blindness

According to Experian Health’s State of Claims 2025 report, 41% of providers now report that more than 1 in 10 claims is denied up from 30% in 2022. Generic billing services track denial volume. They do not map denial root causes to specific CPT code families, modifier combinations, or payer-specific LCD compliance gaps. Without that mapping, prevention is impossible. Recovery is reactive, and recovery always collects less than prevention would have protected.

3. Aged AR Abandonment

The industry benchmark for AR over 90 days as a percentage of total receivables is under 20%. When that threshold is breached which it reliably is at a medical billing company underperforming collection probability collapses to 10-15%. Most vendors in this situation begin prioritizing new claim volume over aged AR recovery, effectively abandoning $60,000-$180,000 in legitimate receivables per year.

Revenue Performance Benchmarks: What Acceptable Looks Like vs. What Exceptional Delivers?

The table below reflects real-world performance differentials across multi-specialty RCM deployments:

The NCR differential alone  7 percentage points between an underperforming vendor (87%) and MBC’s medical billing services platform (94-98%)  translates to $700,000 in additional annual collections on a $10M billing volume. That is not an efficiency gain. That is recovered revenue that was always yours.

7 Performance Indicators That Confirm Your Billing Partner Is Failing

Revenue cycle directors and CFOs at multi-specialty groups should benchmark these seven metrics quarterly:

1. NCR below 92%  specialty benchmarks range 94-98%; anything below 92% is recoverable leakage
2. AR > 90 days exceeding 20%  collection probability drops to 10-15% past this threshold
3. First-pass denial rate above 5%  high-acuity specialties should target sub-3%; above 8% is systemic failure
4. No payer-level NCR breakdown in monthly reporting  aggregate statements hide underperforming contracts
5. Absence of CPT-level denial mapping  root-cause prevention is impossible without procedure-level analytics
6. Days in AR above 25  clean-claim scrubbing infrastructure should deliver 18-22 days
7. Cash-to-net-revenue ratio below 95%  indicates payment posting errors and chronic underpayment acceptance

Any three of these indicators present simultaneously signals structural RCM failure, not a temporary performance variance. The compounding effect at a $5M+ group typically exceeds $300,000 in annual recoverable revenue.

How to Transition Without Disrupting Active Revenue?

The most common objection to switching is operational: what happens to claims in-flight, aged AR, and payer credentialing during the transition? These are legitimate concerns  and precisely why most groups delay a move that would immediately improve their medical billing services performance.

A structured transition requires four parallel workstreams:

• Old AR Recovery Protocol  systematic identification and appeal of aged claims from the outgoing vendor, with a documented $60,000-$180,000 recovery window in the first 90 days
• Payer Credentialing Continuity  parallel credentialing enrollment prevents the 30-60 day claims suspension that unstructured transitions create
• EHR Integration Verification  system-agnostic integration eliminates data migration risk and prevents charge capture disruption
• 90-Day Baseline Benchmarking  establishing NCR, Days in AR, and denial rate baselines in the first 30 days creates the accountability framework that enterprise RCM services require

Groups switching to a performance-optimized platform average a 4-7 percentage point NCR improvement within the first 90 days. On a $10M billing volume, that translates to $400,000-$700,000 in recovered annual revenue  a figure that makes the transition cost structurally irrelevant. 

Is your group leaving $300K+ on the table?

MBC’s 90-Day Revenue Performance Diagnostic identifies hidden revenue leakage across payer contracts, denial patterns, and AR aging — before you sign anything.

Request Your 90-Day Revenue Performance Diagnostic

FAQs

Neel M

With almost 12 years of experience in healthcare revenue cycle management, this Revenue Cycle Specialist brings deep expertise in medical billing, claims optimization, and practice profitability. Shares industry-backed insights focused on improving collections, reducing denials, and driving operational excellence.